Title : Atazanavir exposure is effective during pregnancy regardless of tenofovir use.

Pub. Date : 2015

PMID : 24992294






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: Despite 34% lower atazanavir exposure during pregnancy, atazanavir/ritonavir 300/100 mg once daily generates effective concentrations for protease inhibitor (PI)-naive patients, even if co-administered with tenofovir. Ritonavir serpin family A member 13, pseudogene Homo sapiens